M acrophages are key regulators of innate immunity and inflammation during microbial infection. On detection of the gram-negative bacterial component LPS, macrophages are activated (henceforth LPS activation) to coordinate the induction of innate and adaptive immune responses by producing chemoattractants and inflammatory cytokines. However, in response to overwhelming infection or protracted exposure to LPS, macrophages are initially activated but then shift to a tolerant state (henceforth LPS tolerance) 1,2 . Tolerant macrophages mount a blunted response to further LPS challenge and produce markedly lower amounts of inflammatory cytokines that contribute to the induction of whole-body immunosuppression. Such immunosuppression limits the detrimental effects of sustained inflammation, which otherwise damages multiple organ systems and leads to mortality 3 . Therefore, acute microbial infection elicits an inflammatory response that confers host defense, but persistent and overwhelming microbial infection triggers inflammation followed by a protracted period of tissue-protective immunosuppression 1-3 .
1 h LPS stimulation of BMDMs triggered a small, but significant and highly reproducible increase in mitochondrial oxidative metabolism compared to no stimulation ( Fig. 2a ). Oxygen consumption began to decline after 2 h, followed by a sustained decrease in oxygen consumption below that of unstimulated BMDMs between 4 and 24 h ( Supplementary Fig. 2a and data not shown), probably explaining previous conclusions that LPS-stimulated macrophages shut down oxidative metabolism. Because LPS stimulation enhances glucose use ( Supplementary Fig. 2b and ref. 4 ), we tested if the increase in oxidative metabolism after 1 h of LPS stimulation could be fueled by glucose oxidation. Indeed, treatment with the glucose use inhibitor 2-deoxyglucose (2DG) abrogated such increase in oxidative metabolism, compared to no treatment ( Fig. 2a ).
To further test whether glucose oxidation supports acetyl-CoA production and inflammatory gene induction in LPS-activated BMDMs, we performed glucose isotope tracing using uniformly 13 C-labeled glucose. LPS stimulation for 1.5-3 h enhanced the labeling of glucose-derived carbons into m + 2 citrate-isocitrate and m + 2 acetyl-CoA compared to no stimulation (Fig. 2b,c) , indicating that glucose oxidation fueled acetyl-CoA production during LPS activation. Tracing glucose carbons all the way into histones indicated increased labeling of histones in LPS-stimulated BMDMs compared to no stimulation (Fig. 2d ). 2DG treatment attenuated LPS-inducible histone acetylation at the promoters of Il6 and Il1b ( Fig. 2e ) and expression of Il6 and Il1b mRNA ( Fig. 2f ) compared to no 2DG treatment, indicating that glucose metabolism supported histone acetylation. 2DG reduced the production of IL-6 in LPS-activated BMDMs (Fig. 2g ), while production of mature IL-1β protein, which requires inflammasome activation in BMDMs 25 , was examined no further. Incubation of BMDMs in glucose-free media also led to diminished induction of Il6 and Il1b histone acetylation and mRNA expression ( Supplementary Fig. 2c,d) . These analyses suggested that availability of acetyl-CoA can be limiting for histone acetylation and inflammatory gene induction during LPS activation, and that LPS stimulation boosts glucose oxidation, leading to increased acetyl-CoA production, histone acetylation and inflammatory gene induction.
GPD2 regulates glucose use and oxidation in LPS activation.
During the cytosolic phase of glucose oxidation, glucose-derived electrons are transferred to nicotinamide adenine dinucleotide (NAD + ) at the step catalyzed by glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The malate-aspartate shuttle (MAS) is thought to be ubiquitously deployed during glucose oxidation to transfer reduced nicotinamide adenine dinucleotide (NADH) to complex I of the ETC while regenerating cytosolic NAD +24 . However, the ability of glucose carbons to label histones within 1.5 h of labeling ( Fig. 2d ) relative to steady-state histone labeling in other contexts (approximately 24 h) 26, 27 , suggested an alternative mechanism for rapidly mobilizing glucose oxidation in LPSactivated macrophages. By applying global metabolomics to unstimulated and LPSstimulated BMDMs, we identified the GPS, a glycolytic shunt that delivers glucose-derived electrons to the ETC, as a top metabolic pathway regulated during LPS activation ( Fig. 3a ). In the GPS, the NADH produced by GAPDH is used to reduce dihydroxyacetone phosphate (DHAP) to glycerol 3-phosphate (G3P); mitochondrial glycerol 3-phosphate dehydrogenase (GPD2) couples oxidation of G3P back to DHAP with reduction of its flavin adenine dinucleotide cofactor to FADH 2 , from which electrons flow downward through the ETC to drive mitochondrial respiration ( Fig. 3b , Supplementary  Fig. 3a and Chandel 24 ). We found that LPS stimulation augmented the GPD2 transcript and protein ( Fig. 3c and Supplementary Fig.  3b ). Furthermore, LPS stimulation of BMDMs increased the intrinsic activity of GPD2, compared to no stimulation, as assessed by Seahorse extracellular flux analysis of G3P-driven oxygen consumption ( Supplementary Fig. 3c ).
Using CRISPR-Cas9 genome editing, we generated Gpd2 −/− mice, which were viable and fertile and appeared relatively normal (data not shown). Gpd2 −/− BMDMs had normal expression of CD11b and F4/80 ( Supplementary Fig. 3d ), but lacked GPD2 protein and activity as determined by immunoblotting ( Fig. 3d ) and Seahorse extracellular flux analysis of G3P-driven oxygen consumption ( Fig. 3e ).
In glucose tracing experiments, 1.5-3 h LPS stimulation of wildtype (WT; Gpd2 +/+ ) BMDMs led to a marked increase in the abundance of total and m + 3 G3P ( Fig. 3f ), indicative of enhanced flux through the GPS, while in Gpd2 −/− BMDMs, the abundance of total and m + 3 G3P was further increased (Fig. 3f ), which is consistent with the accumulation of the GPD2 substrate in the absence of GPD2 activity. The 2DG-sensitive, LPS-inducible increase in oxidative metabolism apparent in WT BMDMs ( Fig. 2a and Fig. 3g ) was diminished in Gpd2 −/− BMDMs (Fig. 3g ), indicating a role for GPD2 in mediating glucose oxidation in LPS-activated macrophages. Importantly, the ability of LPS to augment glucose uptake was impaired in Gpd2 −/− BMDMs compared to WT BMDMs (Fig. 3h ), indicating that GPS activity is rate-limiting for glucose use in LPSactivated macrophages. Compared to WT BMDMs, Gpd2 −/− BMDMs had less LPS-inducible glucose labeling into many glycolytic and TCA intermediates ( Supplementary Fig. 4 ) and aerobic glycolysis ( Fig. 3i ), in line with reduced LPS-inducible glucose use and oxidation. These observations indicated that the GPS was a critical regulator of glucose use and oxidation in LPS-activated macrophages. labeling of glucose carbons into citrate and acetyl-CoA was reduced in Gpd2 −/− BMDMs compared to WT BMDMs (Fig. 4a,b ). LPSinducible histone acetylation at the Il6 and Il1b promoters was also attenuated in Gpd2 −/− BMDMs (Fig. 4c ), leading to diminished Il6 and Il1b mRNA expression ( Fig. 4d ) and IL-6 production ( Fig. 4e ), compared to WT BMDMs. Together, these findings indicated that in LPS-activated macrophages, GPS activity boosted glucose oxidation, leading to enhanced carbon substrate availability for histone acetylation and increased inflammatory gene induction ( Supplementary Fig. 5a ).
Impaired inflammatory gene induction in LPS-activated Gpd2
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Glucose use suppresses inflammatory gene induction in LPS tolerance.
During the course of LPS exposure, there is a transition from LPS activation to tolerance 1,2 . Acute LPS stimulation (0-3 h) of BMDMs led to the induction of Il6 and Il1b mRNA during the period of LPS activation, while prolonged LPS stimulation (12-24 h) led to an inability to induce Il6 and Il1b mRNA after a second LPS challenge during the period of LPS tolerance ( Supplementary  Fig. 6a ,b; see refs. 1,2 ). Our data indicated that such shift from inflammatory response induction to suppression was accompanied by a shift from increased to decreased oxidative metabolism ( Supplementary Fig. 2a ). Because increased oxidative metabolism supports inflammatory gene induction during LPS activation, we tested whether the decrease in oxidative metabolism in LPStolerant BMDMs limited the availability of acetyl-CoA for histone acetylation and contributed to suppression of inflammatory gene induction. In contrast to naïve BMDMs, where 3 h LPS stimulation induced glucose conversion into citrate and acetyl-CoA, LPS did not drive glucose conversion into citrate and acetyl-CoA in BMDMs tolerized by 24 h LPS stimulation ( Fig. 5a,b ), suggesting reduced LPS-induced glucose oxidation and acetyl-CoA production in tolerant macrophages. Serendipitously, we found that treating BMDMs with 2DG during a 12 h LPS tolerance induction led to a rescue of oxygen consumption compared to no 2DG treatment ( Fig. 5c ). 2DG treatment during 24 h LPS tolerance induction was also associated with recovery of Il6 and Il1b promoter histone acetylation, Il6 and Il1b mRNA expression and IL-6 production compared to no 2DG Unlabeled treatment ( Fig. 5d-f ). These findings indicated that glucose use was necessary for optimal inhibition of oxidative metabolism and suppression of inflammatory gene induction during LPS tolerance. We next investigated the effects of 2DG treatment on LPS signaling. Nuclear factor kappa B and interferon regulatory factor 3 (IRF3), the master regulators of the LPS-inducible transcriptional response, were robustly activated by LPS in unstimulated BMDMs, but poorly activated in BMDMs tolerized by 24 h LPS stimulation, as indicated by the degradation and resynthesis of I-kappa-B-alpha (IκBα) and activating phosphorylation of IRF3, respectively ( Fig. 5g ,h). 2DG treatment during such LPS tolerance induction had marginal effects on the activation of nuclear factor kappa B and IRF3 ( Fig. 5g,h ), compared to no 2DG treatment, indicating that the effect of 2DG in recovering Il6 and Il1b mRNA might not be due to a general perturbation of LPS signaling. Together, these findings indicated that during prolonged LPS exposure, glucose use was necessary for optimal shutdown of oxidative metabolism and suppression of histone acetylation and inflammatory gene induction.
Rescued inflammatory gene induction in tolerant Gpd2 −/−
BMDMs. Next we tested the role of GPD2-GPS activity in the induction of LPS tolerance. In Gpd2 −/− BMDMs tolerized by 24 h LPS stimulation, tolerance-associated inhibition of oxygen consumption was attenuated compared to their WT counterparts ( Fig.  6a ), indicating that GPD2 was necessary for optimal oxidative metabolism shutdown. Likewise, tolerance-associated suppression of H4ac and H3K27ac at the Il6 and Il1b promoters ( Fig. 6b ), Il6 and Il1b mRNA expression ( Fig. 6c ) and IL-6 production ( Fig. 6d ) were attenuated in Gpd2 -/-BMDMs compared to their WT counterparts, indicating that GPD2 activity was needed for optimal suppression of inflammatory responses. That GPD2 deficiency increased both oxidative metabolism and inflammatory gene expression also linked shutdown of oxidative metabolism to inflammatory gene suppression during tolerance. Similarly to our findings in Gpd2 −/− BMDMs, treatment with the GPD2 inhibitor iGP-1 attenuated the ability of acute LPS stimulation (0-3 h) to induce oxidative metabolism, Il6 and Il1b promoter histone acetylation and Il6 and Il1b mRNA expression during LPS activation ( Supplementary Fig. 7a-c) , but rescued the toleranceassociated shutdown of oxidative metabolism and suppression of Il6 and Il1b promoter histone acetylation and Il6 and Il1b mRNA expression triggered by prolonged LPS stimulation (12-24 h) ( Supplementary Fig. 7d-f ), compared to no inhibitor treatment. Of note, LPS-inducible degradation and resynthesis of IκBα and activating phosphorylation of IRF3 in naïve or tolerized Gpd2 −/− BMDMs was similar to that of their WT counterparts (Fig. 6e,f) . Therefore, GPD2 did not exert broad effects on LPS signaling to influence histone acetylation and inflammatory gene induction during LPS stimulation.
GPD2 regulates RET in tolerized macrophages. We next investigated the mechanisms by which GPD2-GPS activity mediated shutdown of oxidative metabolism during LPS tolerance. Multiple factors are thought to modulate such shutdown, including induction of inducible nitric oxide synthase, IRG1 and RET [12] [13] [14] [15] , as well as repression of the TCA cycle enzyme isocitrate dehydrogenase-1, which allows carbon flux to be shunted from the TCA cycle toward itaconate production. Over a time course of LPS stimulation, WT and Gpd2 −/− BMDMs had similar expression of Nos2, Irg1 (Acod1) and Idh1 mRNA ( Supplementary Fig. 8a ) and levels of itaconate ( Supplementary Fig. 8b) .
We next investigated a potential role for GPD2-mediated glucose oxidation in regulating RET during LPS tolerance. In contrast to forward electron transport (FET), which is the normal operation of the ETC, RET is a consequence of overwhelming electron influx into the ETC, which leads to the saturation of electron transport capacity and creates thermodynamic conditions that allow electron flow in reverse 28 . Therefore, we tested whether sustained GPS activity during prolonged LPS exposure could overwhelm FET capacity leading to RET, which reduced TCA cycling to limit acetyl-CoA production and contribute to inflammatory gene suppression ( Supplementary Fig. 8c ). In contrast to FET, where treatment with the complex I inhibitor rotenone enhances superoxide production, RET-associated reverse electron flow at complex I leads to increased production of superoxide that is sensitive to rotenone 29, 30 . While rotenone treatment increased the levels of superoxide in WT unstimulated BMDMs, it decreased the levels of superoxide in WT BMDMs tolerized by 12 h LPS stimulation (Fig. 7a,b ), indicating that RET was induced after prolonged LPS exposure. The ability of rotenone to reduce superoxide was diminished in Gpd2 −/− tolerant BMDMs compared to their WT counterparts (Fig. 7a,b) , indicating that GPD2 contributed to tolerance-associated RET. Similarly, rotenone stimulated superoxide levels in 2DG-treated tolerant BMDMs compared to no 2DG treatment (Fig. 7a,b) , indicating complete prevention of tolerance-associated RET. Compared to robust NADH oxidation to NAD + at complex I during FET, complex I-associated NADH oxidation is attenuated during RET 28 (Supplementary Fig. 8c ). Using an assay that detects NAD(P)H autofluorescence in real time, and where rotenone acutely blocks complex I activity to reveal NADH oxidation at complex I (ref. 31 ), we found that rotenone robustly enhanced NADH in WT unstimulated BMDMs, which is indicative of robust FET, and modestly enhanced NADH in WT BMDMs tolerized by 12 h LPS stimulation ( Fig. 7c,d) , which is indicative of reduced FET and/or increased RET because the net NADH amount is determined by the relative magnitudes of FET and RET. However, rotenone did not differentially modulate NADH levels between unstimulated and tolerized Gpd2 −/− BMDMs or between 2DG-treated and untreated WT tolerized BMDMs (Fig. 7c,d) , indicating that GPD2 deficiency or 2DG treatment mitigated the reduction of FET and/or the induction of RET during tolerance. These results indicated that sustained GPD2 activity during prolonged LPS exposure overwhelmed the ETC to trigger RET and perturb NADH oxidation, and suggested how GPD2 deficiency could lead to a recovery of oxidative metabolism, acetyl-CoA production, histone acetylation and inflammatory gene induction in tolerized macrophages. Therefore, GPS activity supports inflammatory response induction during acute LPS exposure and inflammatory response suppression during prolonged LPS exposure, acting as a rheostat to link the duration of LPS exposure to the balance of inflammatory response induction and suppression ( Supplementary Fig. 5b ). GPD2 activity suppresses inflammatory responses during septic shock. To ask whether GPD2 regulated inflammatory responses in vivo, we used a model of in vivo LPS tolerance, where a sublethal dose of LPS protects against septic shock triggered by a subsequent lethal dose of LPS. In contrast to counterparts that did not receive the sublethal LPS pretreatment, WT mice receiving the pretreatment markedly suppressed circulating amounts of IL-6, as detected 6 h after lethal LPS challenge (Fig. 8a ). Compared to their WT counterparts, Gpd2 −/− mice receiving the pretreatment had increased circulating amounts of IL-6, indicating attenuated suppression of inflammatory responses (Fig. 8a) . Furthermore, the drop in body temperature induced 6 h after lethal LPS challenge was exaggerated in Gpd2 −/− mice compared to WT mice (Fig. 8b) , indicating an augmented response to lethal LPS challenge. Finally, WT mice that received a sublethal LPS pretreatment survived the subsequent lethal LPS challenge, while Gpd2 −/− mice succumbed ( Fig. 8c ), suggesting a profound defect in LPS tolerance and immunosuppression in the absence of GPD2. Collectively, the data indicate that GPD2 suppressed inflammatory responses to protect against a drop in body temperature and mortality during septic shock.
Discussion
In this study, we made several findings regarding the role of glucose use in controlling the fate of macrophages exposed to LPS. We showed that oxidative metabolism was increased in LPS-activated BMDMs, fueling the production of acetyl-CoA to provide carbon substrate for histone acetylation at the Il6 and Il1b promoters. Our findings define a previously unknown role for glucose use in LPSstimulated macrophages-namely glucose oxidation-as well as an underpinning basis by which such glucose use drove LPS activation. We also showed that the acetyl-CoA-producing enzyme ACLY was a key regulator of this process that supported histone acetylation and inflammatory gene induction during LPS activation. We identified GPD2 and the GPS as key regulators of glucose oxidation in LPS-stimulated macrophages. Like the MAS, the GPS regenerates cytosolic NAD + to maintain redox balance during glucose oxidation; unlike the MAS, GPS activity is restricted to a limited number of tissues because GPD2 is expressed in a tissuespecific manner 32, 33 . The role of GPD2 in macrophages is unknown, except that its biochemical activity is increased after microbial infection 34 . Here we showed that LPS stimulation increased flux through the GPS by augmenting glucose use (which stimulates substrate delivery to the GPS), GPD2 expression and the intrinsic activity of GPD2. Such increase of GPS flux is noteworthy given that macrophages can deploy the MAS to maintain glucose oxidation 35 , and suggests a nonredundant role for the GPS in regulating macrophage responses to LPS.
Although shutdown of oxidative metabolism is a metabolic hallmark of LPS-stimulated macrophages, its role in modulating macrophage responses to LPS had been unclear 4, 10, 36 . Here we showed that such shutdown occurred at 12-24 h after LPS stimulation, after the initial increase in oxidative metabolism, and contributed to reduced acetyl-CoA production, histone acetylation and inflammatory gene induction in tolerant macrophages. We propose that shutdown of oxidative metabolism is central to metabolic reprogramming during LPS tolerance, while induction of aerobic glycolysis is presumably a compensatory mechanism to support cellular bioenergetics (that is, ATP production) in the face of oxidative metabolism shutdown.
We found that GPD2 and the GPS were important regulators of tolerance-associated shutdown of oxidative metabolism. Inhibiting glucose use or GPD2 deficiency was sufficient for partial restoration of oxidative metabolism, leading to a partial recovery of histone acetylation and inflammatory gene induction in tolerant macrophages, as well as increased IL-6 production and mortality during septic shock. We propose a model where GPS activity influences oxidative metabolism to modulate a shift from inflammatory response induction to suppression. During acute LPS exposure, GPS activity drives FET and acetyl-CoA production to enhance histone acetylation and inflammatory gene induction; however, during prolonged LPS exposure, sustained GPS activity eventually saturates electron transport capacity to trigger RET and limit acetyl-CoA production for histone acetylation and inflammatory gene induction. Therefore, GPS activity triggered RET as a consequence of its initial boost of FET, allowing the GPS to integrate the duration of LPS exposure with the activity of the ETC. In this manner, GPS activity supported inflammatory responses after acute microbial exposure, but contributed to inflammatory response suppression after prolonged microbial exposure. Inflammation confers host defense at the expense of tissue damage and must be carefully regulated to balance its beneficial and detrimental effects; GPS activity, by integrating the extent of microbial exposure to inflammatory response induction versus suppression, may provide one such balancing mechanism. Our detailed metabolic analyses implicated histone acetylation at inflammatory genes as a key target by which GPD2 regulates inflammatory gene expression. In contrast, we found no broad effects of GPD2 deficiency on LPS-inducible nuclear factor kappa B and IRF3 activation, or LPS-inducible gene expression as assessed by RNA sequencing (data not shown). However, we do not exclude the possibility that GPD2 activity impinges on specific aspects of LPS signaling to contribute to its regulation of inflammatory gene expression. For example, GPD2-mediated glucose oxidation could influence the expression of specific signaling proteins, via effects on promoter histone acetylation and protein acetylation, an effect nonexclusive with its modulation of histone acetylation at inflammatory genes. Additionally, how GPD2-mediated glucose oxidation and acetyl-CoA production can modulate histone acetylation and the expression of a subset of LPS-inducible genes is unclear. One possibility is that ACLY is recruited to chromatin, producing a local pool of acetyl-CoA that regulates histone acetylation in a gene-specific manner. Precedence for such gene-specific association and regulation has been established by the metabolic machinery that produces S-adenosyl-L-methionine, the substrate for histone and DNA methylation 37 .
Our findings indicate that increased oxidative metabolism is a common feature of LPS-and IL-4-activated macrophages, and that one consequence of this process is enhanced provision of acetyl-CoA, which is otherwise limiting for histone acetylation and inducible gene expression. Therefore, polarizing signals like LPS and IL-4 mobilize oxidative metabolism to drive optimal gene induction and macrophage activation. In the case of LPS-stimulated macrophages, this process is further exploited to eventually influence oxidative metabolism shutdown and inflammatory gene suppression. In this regard, our conclusions appear in conflict with those of a recent study showing that RET-associated reactive oxygen species production drives Il1b induction 16 . However, that study did not perform a kinetic analysis of LPS stimulation. In our study, we examined glucose oxidation, oxidative metabolism, FET/RET and inflammatory gene induction or suppression over a time course, allowing us to address how dynamic changes to oxidative metabolism and FET/ RET could affect the dynamic changes to inflammatory gene induction or suppression that occur over the course of LPS exposure.
In conclusion, we propose that GPD2-GPS-mediated glucose oxidation has a unique, nonredundant role in optimal control of inflammatory gene induction and suppression. Compared with the MAS, GPS activity may allow for rapid and robust glucose oxidation that drives ETC flux and inflammatory gene expression during LPS activation, but in the event of sustained LPS exposure, contributes to RET induction. Therefore, deployment of the GPS in the high metabolic state of LPS-stimulated macrophages enables GPD2 activity to act as a rheostat that couples the duration of LPS exposure to ETC directionality to enable appropriate modulation of inflammatory response induction and suppression.
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was measured by MitoSOX Red Mitochondrial Superoxide Indicator (Thermo Fisher Scientific) according to the manufacturer's protocol. Briefly, BMDMs were left unstimulated or stimulated with LPS for the indicated times and then labeled with 2.5 μM MitoSOX Red in the final 15 min of treatment, followed by washout and no fixation. The mean fluorescence intensity of MitoSOX in the phycoerythrin channel was measured to determine levels of mitochondrial superoxide at the time of labeling. Duplicate cell culture samples were run for each condition in every experiment. All samples were acquired on a FACS Fortessa flow cytometer (BD Biosciences); the FlowJo software v.10.4 (FlowJo LLC) was used to analyze the data.
Statistical analysis.
Data are shown as the mean or the mean ± s.e.m. or s.d., as indicated in the figure legends. Statistical significance was determined using a twotailed Student's t-test, two-way analysis of variance (ANOVA) with Sidak's multiple comparisons test or Mantel-Cox test using Prism v.7.0a (GraphPad Software), as indicated in the figure legends. All statistical tests were performed using Prism, except for the pathway enrichment analysis of steady-state metabolite profiling, for which MetaboAnalyst was used to generate the statistics. *, **, *** and **** in the figures denote P ≤ 0.05, P ≤ 0.01, P ≤ 0.001 and P ≤ 0.0001, respectively.
